The rise (and possible fall) of ketamine treatment in New Zealand

Roger Mulder, Ben Beaglehole, James Foulds

New Zealand Medical Journal August 25, 2023 DOI: 10.26635/6965.e1581 (opens in new tab)

Study at a glance

AI-extracted from the abstract

Characteristics	Peer reviewed
Topics	Esketamine Ketamine

Abstract

The New Zealand Medical Journal (NZMJ) is the principal scientific journal for the medical profession in New Zealand. The Journal has become a fundamental resource for providing research and written pieces from the health and medical industry.

A systematic review of the print media representation of ketamine treatments for psychiatric disorders BJPsych Open June 7, 2023 11 citations
Drug dependence and prescribing ketamine for treatment-resistant depression in Australia and New Zealand. The Australian and New Zealand journal of psychiatry October 1, 2024 10 citations
Multidisciplinary development of guidelines for ketamine treatment for treatment-resistant major depression disorder for use by adult specialist mental health services in New Zealand BJPsych Open October 13, 2023 9 citations
Research trends and hotspots of ketamine from 2014 to 2023: a bibliometric analysis. Frontiers in Neuroscience 2024 2 citations
Ketamine Journal When Monsters Speak June 24, 2024

Study at a glance

Abstract

Related reading